Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Coccidiosis
4.2.2 Advancements in Veterinary Healthcare
4.3 Market Restraints
4.3.1 Availability of Alternative Treatment Options in the Market
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Drug Type
5.1.1 Ionophore Anticoccidials
5.1.2 Chemical Derivative Anticoccidials
5.2 By Animal
5.2.1 Poultry
5.2.2 Swine
5.2.3 Fish
5.2.4 Cattle
5.2.5 Companion Animals
5.3 Geography
5.3.1 Asia-Pacific
5.3.1.1 China
5.3.1.2 Japan
5.3.1.3 India
5.3.1.4 Australia
5.3.1.5 South Korea
5.3.1.6 Rest of Asia-Pacific


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Elanco
6.1.2 Vetoquinol SA
6.1.3 Huvepharma
6.1.4 Virbac
6.1.5 Zoetis Animal Healthcare
6.1.6 MSD Animal Health
6.1.7 Boehringer Ingelheim International GmbH
6.1.8 Ceva Animal Health Inc
6.1.9 Bayer AG


7 MARKET OPPORTUNITIES AND FUTURE TRENDS